IRD earnings: a positive outcome, +6.4%

On March 30, 2023, Opus Genetics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +6.4% in the window around the event. It had already run +6.7% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.